English

• 

• 1. [1] D.G. Wishka, P. Beagley, J. Lyon, et al., A concise synthesis of 6-oxa-3-azabicyclo[3.1.1]heptane hydrotosylate, Synthesis 16 (2011) 2619-2624.[1] D.G. Wishka, P. Beagley, J. Lyon, et al., A concise synthesis of 6-oxa-3-azabicyclo[3.1.1]heptane hydrotosylate, Synthesis 16 (2011) 2619-2624.

  2. [2] A.J. Roecker, P.J. Coleman, S.P. Mercer, et al., Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP, Bioorg. Med. Chem. Lett. 17 (2007) 5677-5682.[2] A.J. Roecker, P.J. Coleman, S.P. Mercer, et al., Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP, Bioorg. Med. Chem. Lett. 17 (2007) 5677-5682.

  3. [3] P.S. Portoghese, J.G. Turcotte, Synthesis and nuclear magnetic resonance investigation of some chiral 2-oxa-5-azabicyclo[2.2.1]heptane derivatives, Tetrahedron 27 (1971) 961-967.[3] P.S. Portoghese, J.G. Turcotte, Synthesis and nuclear magnetic resonance investigation of some chiral 2-oxa-5-azabicyclo[2.2.1]heptane derivatives, Tetrahedron 27 (1971) 961-967.

  4. [4] P.S. Portoghese, J.G. Turcotte, Stereochemical studies on medicinal agents. 9. Bicyclic bases. Synthesis and biological activities of epimeric quaternary derivatives of 2-oxa-5-azabicyclo[2.2.1]heptane, J. Med. Chem. 14 (1971) 288-291.[4] P.S. Portoghese, J.G. Turcotte, Stereochemical studies on medicinal agents. 9. Bicyclic bases. Synthesis and biological activities of epimeric quaternary derivatives of 2-oxa-5-azabicyclo[2.2.1]heptane, J. Med. Chem. 14 (1971) 288-291.

  5. [5] P.Y. Sun, Quinazoline compounds or their medical salts and preparation and medical usage thereof, WO2006081741.[5] P.Y. Sun, Quinazoline compounds or their medical salts and preparation and medical usage thereof, WO2006081741.

  6. [6] R. Ganorkar, A. Natarajan, A. Mamai, J.S. Madalengoitia, Synthesis of conformationally constrained lysine analogues, J. Org. Chem. 71 (2006) 5004-5010.[6] R. Ganorkar, A. Natarajan, A. Mamai, J.S. Madalengoitia, Synthesis of conformationally constrained lysine analogues, J. Org. Chem. 71 (2006) 5004-5010.

  7. [7] F. Fache, O. Piva, Synthesis and applications of the first polyfluorous proline derivative, Tetrahedron: Asymmetry 14 (2003) 139-143.[7] F. Fache, O. Piva, Synthesis and applications of the first polyfluorous proline derivative, Tetrahedron: Asymmetry 14 (2003) 139-143.

  8. [8] S.C. Mayer, J. Ramanjulu, M.D. Vera, A.J. Pfizenmayer, M.M. Joullié, Synthesis of new didemnin B analogs for investigations of structure/biological activity relationships, J. Org. Chem. 59 (1994) 5192-5205.[8] S.C. Mayer, J. Ramanjulu, M.D. Vera, A.J. Pfizenmayer, M.M. Joullié, Synthesis of new didemnin B analogs for investigations of structure/biological activity relationships, J. Org. Chem. 59 (1994) 5192-5205.

  9. [9] J. Chiba, G. Takayama, T. Takashi, et al., Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonists, Bioorg. Med. Chem. 14 (2006) 2725-2746.[9] J. Chiba, G. Takayama, T. Takashi, et al., Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonists, Bioorg. Med. Chem. 14 (2006) 2725-2746.

  10. [10] F.M. Kaspersen, U.K. Pandit, Unconventional nucleotide analogues. Part XⅢ. (2S,4S)-2-hydroxymethyl-and 2-carboxy-4-(purin-9-yl) pyrrolidines, J. Chem. Soc. Perkin Trans. 1 (1975) 1617-1622.[10] F.M. Kaspersen, U.K. Pandit, Unconventional nucleotide analogues. Part XⅢ. (2S,4S)-2-hydroxymethyl-and 2-carboxy-4-(purin-9-yl) pyrrolidines, J. Chem. Soc. Perkin Trans. 1 (1975) 1617-1622.

•